Ryoji Noyori
Ryoji Noyori
Ryōji Noyoriis a Japanese chemist. He won the Nobel Prize in Chemistry in 2001. Noyori shared half of the prize with William S. Knowles for the study of chirally catalyzed hydrogenations; the second half of the prize went to K. Barry Sharpless for his study in chirally catalyzed oxidation reactions...
NationalityJapanese
ProfessionScientist
Date of Birth3 September 1938
CountryJapan
chemical director gifted influenced life profession research strongly
My father, Kaneki, was a gifted research director of a chemical company, and his profession strongly influenced the path of my life.
appointed associate enjoying full instructor major mere national prepared professor work
I was a mere 29-year-old instructor at Kyoto, enjoying daily research work with some young students. Nothing had prepared me to be a professor at a major national university. Being too young and inexperienced to be a Full Professor, I was first appointed Associate Professor of Chemistry.
achieved attracted numerous outside people scientists
RIKEN has attracted numerous outstanding scientists from inside and outside Japan, and these people have achieved creative and outstanding results.
activities affiliated ages attended elementary enjoyed except high kobe middle moved period school six twelve university war
Except for a short period at the end of World War II, I attended an elementary school affiliated to Kobe University from ages six to twelve and then moved on to Nada Middle and High School from ages twelve to eighteen. I enjoyed many out-door activities in my youth.
respect serious structural synthetic
The structural difference between enantiomers can be serious with respect to the actions of synthetic drugs.
active age entered known kyoto
In 1957, at the age of 18, I entered Kyoto University, which was known to be the most active institution in the research of polymer chemistry.
human interact marked molecules proper resulting sites
Chiral receptor sites in the human body interact only with drug molecules having the proper absolute configuration, resulting in marked differences in the pharmacological activities of enantiomers.